Gallacher Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $456K | Buy |
6,532
+579
| +10% | +$40.5K | 0.21% | 137 |
|
|
2025
Q1 | $438K | Buy |
5,953
+332
| +6% | +$24.4K | 0.21% | 135 |
|
|
2024
Q4 | $368K | Buy |
5,621
+78
| +1% | +$5.11K | 0.18% | 151 |
|
|
2024
Q3 | $432K | Buy |
5,543
+409
| +8% | +$31.9K | 0.2% | 131 |
|
|
2024
Q2 | $400K | Sell |
5,134
-297
| -5% | -$23.2K | 0.21% | 126 |
|
|
2024
Q1 | $368K | Buy |
5,431
+150
| +3% | +$10.2K | 0.19% | 145 |
|
|
2023
Q4 | $356K | Buy |
5,281
+42
| +0.8% | +$2.83K | 0.2% | 130 |
|
|
2023
Q3 | $355K | Buy |
5,239
+442
| +9% | +$29.9K | 0.22% | 107 |
|
|
2023
Q2 | $343K | Buy |
4,797
+308
| +7% | +$22K | 0.2% | 142 |
|
|
2023
Q1 | $312K | Buy |
4,489
+372
| +9% | +$25.8K | 0.19% | 152 |
|
|
2022
Q4 | $279K | Buy |
+4,117
| New | +$279K | 0.17% | 151 |
|